Jianhua Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianhua Li has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Chuanzhen Liu
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Jinan 250012, Shandong, China; Shandong University, No. 27, South Shanda Road, Jinan 250100, Shandong, China; Pantheum Biotechnology Co., Ltd, Jinan 250012, Shandong, China
1 shared publication- Chuanzhen Liu
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China
1 shared publication - Guangqing Cao
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China
1 shared publication - Kai Liu
Department of Cardiovascular Surgery, Qilu Hospital, Shandong University, Jinan, China
1 shared publication - Kaiming Wei
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China
1 shared publication Lingwei Meng
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Jinan 250012, Shandong, China
1 shared publication
Latest Publications
- 14 May 2024
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (2) , 1045-1054
Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling
Pulmonary arterial hypertension (PAH) is a pathophysiological syndrome that is extremely difficult to manage, and there is currently no effective treatment. We want to elucidate the therapeutic effect of ethyl pyruvate (EP) on PAH and its possible mechanism. Pulmonary artery endothelial cells (PAECs) were cultured in conventional low-oxygen environments, and cellular proliferation was monitored after treatment with EP. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 was detected by Western blot. After hyperkinetic PAH rabbits’ models were treated with EP, hemodynamic data were collected. Right ventricular hypertrophy and pulmonary vascular remodeling were evaluated. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 protein was also detected after using autophagy inhibitor and agonists. We found that EP could inhibit PAECs proliferation. After EP treatment, expression of p-PI3K/Akt was upregulated in vitro and in vivo. LC3-II and Beclin-1 were inhibited and their expression was lower after autophagy inhibitor was given, while after administration of autophagy agonists, their expression was higher than that in the EP alone group. Besides, EP attenuated PAH, and right ventricular hypertrophy and pulmonary vascular remodeling were also reversed. EP can reduce PAH and reverse vascular remodeling which is associated with inhibition of autophagy in PAECs based on PI3K-Akt signaling pathway. The results of this study can provide surgical opportunities for patients with severe PAH caused by congenital heart disease in clinical cardiovascular surgery.
- 14 May 2024
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (2) , 1045-1054
Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling
Pulmonary arterial hypertension (PAH) is a pathophysiological syndrome that is extremely difficult to manage, and there is currently no effective treatment. We want to elucidate the therapeutic effect of ethyl pyruvate (EP) on PAH and its possible mechanism. Pulmonary artery endothelial cells (PAECs) were cultured in conventional low-oxygen environments, and cellular proliferation was monitored after treatment with EP. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 was detected by Western blot. After hyperkinetic PAH rabbits’ models were treated with EP, hemodynamic data were collected. Right ventricular hypertrophy and pulmonary vascular remodeling were evaluated. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 protein was also detected after using autophagy inhibitor and agonists. We found that EP could inhibit PAECs proliferation. After EP treatment, expression of p-PI3K/Akt was upregulated in vitro and in vivo. LC3-II and Beclin-1 were inhibited and their expression was lower after autophagy inhibitor was given, while after administration of autophagy agonists, their expression was higher than that in the EP alone group. Besides, EP attenuated PAH, and right ventricular hypertrophy and pulmonary vascular remodeling were also reversed. EP can reduce PAH and reverse vascular remodeling which is associated with inhibition of autophagy in PAECs based on PI3K-Akt signaling pathway. The results of this study can provide surgical opportunities for patients with severe PAH caused by congenital heart disease in clinical cardiovascular surgery.
- 28 March 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 355, 50-56
A Mendelian randomization-based study of the causal relationship between leisure sedentary behavior and delirium
- 28 March 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 355, 50-56
A Mendelian randomization-based study of the causal relationship between leisure sedentary behavior and delirium